| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |